3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Triple Negative Breast Neoplasms
13
Breast Neoplasms
11
Carcinoma, Transitional Cell
6
Carcinoma, Non-Small-Cell Lung
5
Urinary Bladder Neoplasms
4
Neoplasm Metastasis
4
Lung Neoplasms
3
Small Cell Lung Carcinoma
2
Urothelial Bladder Carcinoma
1
Salivary Gland Neoplasms
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Prostatic Neoplasms
1
Neoplasm, Residual
1
Muscle Invasive Bladder Urothelial Carcinoma
1
Metastatic Urothelial Cancer
1
Lung Diseases
1
Locally Advanced or Metastatic Unresectable Urothelial Cancer
1
Localized Muscle Invasive Bladder Urothelial Carcinoma
1
Liver Failure
1
HRD Cancer
1
Glioblastoma
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Drug-Related Side Effects and Adverse Reactions
1
Carcinoma, Small Cell
1
Brain Neoplasms
1
Advanced Solid Tumors
1
Interventions
Magnetic Resonance Spectroscopy
15
Specimen Handling
12
Cisplatin
9
Platinum
7
1,2-diaminocyclohexaneplatinum II citrate
7
pembrolizumab
6
Radiotherapy, Intensity-Modulated
6
Cetuximab
6
Biopsy
6
Radiation
5
Carboplatin
5
Radiotherapy
4
(225)Ac-DOTA-c(RGDyK)
4
cemiplimab
3
X-Rays
3
Taxes
3
Standard of Care
3
Paclitaxel
3
Nivolumab
3
Immunoglobulin G
3
Disulfides
3
ipatasertib
2
Ultrasonography
2
Practice Guidelines as Topic
2
Interviews as Topic
2
Fluorodeoxyglucose F18
2
Drug Therapy
2
Docetaxel
2
Bevacizumab
2
trastuzumab deruxtecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Mouth Neoplasms
×
sacituzumab govitecan
×
90 days
×
Clear all
No trials found.